U
UroGen Pharma Ltd. (URGN)
NGM – Real vaqt narxi. Valyuta: USD
48.22
+1.11 (2.36%)
Bozor ochiq: Aug 12, 2026, 11:51 AM EDT
47.13
+0.02 (0.04%)
Oldingi bozordan keyin: Aug 11, 2026, 7:36 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
48.22
+1.11 (2.36%)
Bozor ochiq: Aug 12, 2026, 11:51 AM EDT
47.13
+0.02 (0.04%)
Oldingi bozordan keyin: Aug 11, 2026, 7:36 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $196.1M naqd pul zahiralaridan ($80.5M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $235.4M jami joriy majburiyatlardan $61.9M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-1.5) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (0.0x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$35.1M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.80 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 3.41 | 5.63 | 10 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.78 | 1.04 | 2.0 | |
| Foiz to‘lov qoplami | 0.01 | -16.91 | 2.0 | |
| O‘rtacha ball | 5.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 64M | 83M | 90M | 110M | 189M |
| Yalpi foyda | 57M | 73M | 82M | 97M | 171M |
| Operatsion daromad | -79M | -66M | -97M | -125M | -67M |
| Sof foyda | -110M | -102M | -127M | -153M | -98M |
| EBITDA | -77M | -64M | -96M | -122M | -64M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 229.62 | 114.77 | 10 |
| Keyingi chorak | 186.03 | 174.11 | 10 |
| Joriy yil | 193.45 | 93 | 10 |
| Keyingi yil | 68.06 | 1457.4 | 10 |
| O‘rtacha ball | 10 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 42.18 | 39.12 | 40.43 | 22.68 | 10 |
| Yil/Yil | 199.22 | 71.26 | 73.33 | 12.98 | 9.5 |
| 3 yil o‘rtacha | 19.75 | -12.72 | 11.58 | -27.19 | 4.5 |
| 5 yil o‘rtacha | 80.08 | -4.69 | 10.82 | -12.81 | 4.8 |
| O‘rtacha ball | 7.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |